Literature DB >> 6174491

Radiotherapy of unresectable pancreatic carcinoma: a six year experience with 104 patients.

R Whittington, R R Dobelbower, M Mohiuddin, F E Rosato, S M Weiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6174491     DOI： 10.1016/0360-3016(81)90185-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  9 in total

Review 1.  Current and emerging treatments for pancreatic cancer.

Authors:  W F Regine; W J John; M Mohiuddin
Journal:  Drugs Aging       Date:  1997-10       Impact factor: 3.923

Review 2.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

3.  Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial.

Authors:  K D Lillemoe; J L Cameron; H S Kaufman; C J Yeo; H A Pitt; P K Sauter
Journal:  Ann Surg       Date:  1993-05       Impact factor: 12.969

4.  Intraoperative electron beam therapy for unresectable cancer of the pancreas.

Authors:  R R Dobelbower; A elTaki; F Bagne; M I Ajlouni; A J Milligan; D G Bronn
Journal:  Int J Pancreatol       Date:  1989-02

5.  Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function.

Authors:  I Ihse; E Zoucas; E Gyllstedt; R Lillo-Gil; A Andrén-Sandberg
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

6.  Intraoperative radiation therapy for patients with pancreatic carcinoma.

Authors:  W U Shipley; J E Tepper; A L Warshaw; E L Orlow
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

7.  Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma.

Authors:  W U Shipley; W C Wood; J E Tepper; A L Warshaw; E L Orlow; S D Kaufman; G E Battit; G L Nardi
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

8.  MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).

Authors:  M Pavic; M Niyazi; L Wilke; S Corradini; M Vornhülz; U Mansmann; A Al Tawil; R Fritsch; J Hörner-Rieber; J Debus; M Guckenberger; C Belka; J Mayerle; G Beyer
Journal:  Radiat Oncol       Date:  2022-01-25       Impact factor: 3.481

9.  Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer: Retrospective cohort study, 7-year experience with 247 patients at the National Cancer Center in China.

Authors:  Yingtai Chen; Xu Che; Jianwei Zhang; Huang Huang; Dongbing Zhao; Yantao Tian; Yexiong Li; Qinfu Feng; Zhihui Zhang; Qinglong Jiang; Shuisheng Zhang; Xiaolong Tang; Xianghui Huang; Yunmian Chu; Jianghu Zhang; Yuemin Sun; Yawei Zhang; Chengfeng Wang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.